Related Experiment Videos

Effect of sulfamethazine on mixed function oxidase in chickens

K M Kodam1, S P Govindwar

  • 1Department of Chemistry, Shivaji University, Kolhapur, India.

Veterinary and Human Toxicology
|August 1, 1995
PubMed

Insights

Sulfamethazine (SMZ) at 150 mg/kg for 1-3 days significantly boosted drug metabolism enzymes in chickens. Higher doses or longer durations reduced these effects, indicating SMZ

Area of Science:

  • Pharmacology
  • Veterinary Medicine
  • Biochemistry

Background:

  • Sulfamethazine (SMZ) is a widely used sulfonamide antibiotic.
  • Understanding its metabolic effects in poultry is crucial for drug safety and efficacy.
  • Cytochrome P-450 enzymes are key in drug metabolism.

Purpose of the Study:

  • To investigate the impact of SMZ administration on drug-metabolizing enzymes in chickens.
  • To determine dose- and duration-dependent effects of SMZ on these enzymes.

Main Methods:

  • Chickens were administered varying doses of SMZ (150 mg/kg and 300 mg/kg) for 1, 3, or 5 days.
  • Levels of cytochrome P-450, cytochrome b5, and the activities of aminopyrine N-demethylase, aniline hydroxylase, and glutathione S-transferase were measured.
  • In vitro inhibition assays were performed.

Main Results:

  • A dose of 150 mg/kg SMZ for 1 or 3 days significantly induced cytochrome P-450, cytochrome b5, and related enzyme activities.
  • Higher dose (300 mg/kg) or longer duration (5 days) of SMZ administration led to decreased or no significant changes in these parameters.
  • In vitro studies suggested SMZ acts as a substrate for the mixed-function oxidase system.

Conclusions:

  • SMZ exhibits dose- and duration-dependent effects on hepatic drug-metabolizing enzymes in chickens.
  • The 150 mg/kg dose for short durations appears to be a potent inducer of specific cytochrome P-450 forms.
  • These findings highlight the complex interaction between SMZ and the avian metabolic system.

Related Concept Videos